The East Asian paradox: an updated position statement on the challenges to the current antithrombotic strategy in patients with cardiovascular disease
East Asian patients have reduced anti-ischemic benefits and increased bleeding risk during
antithrombotic therapies compared with Caucasian patients. As potent P2Y 12 receptor …
antithrombotic therapies compared with Caucasian patients. As potent P2Y 12 receptor …
Consensus and update on the definition of on-treatment platelet reactivity to adenosine diphosphate associated with ischemia and bleeding
Dual antiplatelet therapy with aspirin and a P2Y12 receptor blocker is a key strategy to
reduce platelet reactivity and to prevent thrombotic events in patients treated with …
reduce platelet reactivity and to prevent thrombotic events in patients treated with …
Expert consensus document: World Heart Federation expert consensus statement on antiplatelet therapy in East Asian patients with ACS or undergoing PCI
Guideline recommendations on the use of dual antiplatelet therapy (DAPT) in patients with
acute coronary syndromes and in those undergoing percutaneous coronary intervention …
acute coronary syndromes and in those undergoing percutaneous coronary intervention …
“East asian paradox”: challenge for the current antiplatelet strategy of “one-guideline-fits-all races” in acute coronary syndrome
YH Jeong - Current cardiology reports, 2014 - Springer
Clinical experiences have suggested that East Asians show the higher risk of warfarin-
related intracranial hemorrhage compared with Westerners. Therefore, different target of the …
related intracranial hemorrhage compared with Westerners. Therefore, different target of the …
[HTML][HTML] Acute coronary syndrome in the Asia-Pacific region
MY Chan, X Du, D Eccleston, C Ma… - international Journal of …, 2016 - Elsevier
More than 4.2 billion inhabitants populate the Asia-Pacific region. Acute coronary syndrome
(ACS) is now a major cause of death and disability in this region with in-hospital mortality …
(ACS) is now a major cause of death and disability in this region with in-hospital mortality …
Platelet function tests in clinical cardiology: unfulfilled expectations
This review is a critical evaluation of publications in the past decade on the usefulness of
platelet function tests (PFTs) in clinical cardiology, in aiding diagnosis, predicting risk, and …
platelet function tests (PFTs) in clinical cardiology, in aiding diagnosis, predicting risk, and …
Comparison of short-term clinical outcomes between ticagrelor versus clopidogrel in patients with acute myocardial infarction undergoing successful revascularization; …
KH Park, MH Jeong, Y Ahn, TH Ahn, KB Seung… - International journal of …, 2016 - Elsevier
Background Although ticagrelor has been well-known to improve clinical outcomes in
patients with acute myocardial infarction (AMI) without increased bleeding risk, its clinical …
patients with acute myocardial infarction (AMI) without increased bleeding risk, its clinical …
2018 update of expert consensus statement on antiplatelet therapy in East Asian patients with ACS or undergoing PCI
Y Huo, YH Jeong, Y Gong, D Wang, B He, J Chen… - Science Bulletin, 2019 - Elsevier
East Asians are the most populous race in the world and their health status is an important
global issue. Compared with Caucasian populations, East Asian patients have a different …
global issue. Compared with Caucasian populations, East Asian patients have a different …
World Heart Federation expert consensus statement on antiplatelet therapy in East Asian patients with ACS or undergoing PCI
Guideline recommendations on the use of dual antiplatelet therapy (DAPT) in patients with
acute coronary syndromes and in those undergoing percutaneous coronary intervention …
acute coronary syndromes and in those undergoing percutaneous coronary intervention …
High Platelet Reactivity Combined with CYP2C19 Genotype in Predicting Outcomes in East Asian Patients Undergoing Percutaneous Coronary Intervention
Loss‐of‐function (LoF) alleles of cytochrome P450 2C19 (CYP2C19), which are prevalent in
East Asians, are linked to high platelet reactivity (HPR) phenotype and poor prognosis. We …
East Asians, are linked to high platelet reactivity (HPR) phenotype and poor prognosis. We …